Humatech SEC Filings

Type
Report
Date
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/23/2005
NT 10-QNT 10-Q-Formular3/18/2005
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/4/2005
10QSB10QSB-Formular12/27/2004
NT 10-QNT 10-Q-Formular12/15/2004
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/15/2004
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/28/2004
10QSB10QSB-Formular10/4/2004
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/22/2004
NT 10-QNT 10-Q-Formular9/14/2004
10KSB10KSB-Formular9/10/2004
NT 10-KNT 10-K-Formular7/30/2004
S-8S-8-Formular7/12/2004
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/6/2004
4Insidertransaktion5/20/2004
4Insidertransaktion5/20/2004
4Insidertransaktion5/13/2004
REGDEXREGDEX-Formular5/6/2004
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/16/2004
10QSB10QSB-Formular3/24/2004
NT 10-QNT 10-Q-Formular3/16/2004
10QSB10QSB-Formular1/28/2004
10QSB10QSB-Formular1/28/2004
4Insidertransaktion12/16/2003
10KSB10KSB-Formular12/12/2003
4Insidertransaktion11/12/2003
4Insidertransaktion11/6/2003
4Insidertransaktion10/31/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/28/2003
4/A4/A-Formular10/23/2003
4Insidertransaktion10/23/2003
4Insidertransaktion10/23/2003
4Insidertransaktion10/10/2003
NT 10-QNT 10-Q-Formular9/15/2003
NT 10-KNT 10-K-Formular7/29/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/28/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/18/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/12/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/23/2003
DEF 14ADEF 14A-Formular4/8/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/7/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/3/2003
4Insidertransaktion4/1/2003
PRE 14APRE 14A-Formular3/28/2003
10QSB10QSB-Formular3/24/2003
NT 10-QNT 10-Q-Formular3/17/2003
10QSB/A10QSB/A-Formular2/24/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/24/2003
10QSB/A10QSB/A-Formular2/24/2003
10KSB/A10KSB/A-Formular2/24/2003
10QSB/A10QSB/A-Formular2/24/2003
10QSB/A10QSB/A-Formular2/24/2003
10QSB/A10QSB/A-Formular2/24/2003
10QSB/A10QSB/A-Formular2/13/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/13/2003
10KSB/A10KSB/A-Formular2/13/2003
10QSB/A10QSB/A-Formular2/13/2003
10QSB/A10QSB/A-Formular2/13/2003
10QSB/A10QSB/A-Formular2/13/2003
10KSB/A10KSB/A-Formular2/13/2003
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/16/2003
10QSB10QSB-Formular12/23/2002
NT 10-QNT 10-Q-Formular12/16/2002
4Insidertransaktion11/21/2002
10QSB10QSB-Formular9/17/2002
NT 10-QNT 10-Q-Formular9/16/2002
10KSB10KSB-Formular8/1/2002
NT 10-KNT 10-K-Formular7/29/2002
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/12/2002
S-8S-8-Formular6/3/2002
10QSB10QSB-Formular3/15/2002
REGDEXREGDEX-Formular1/23/2002
10QSB10QSB-Formular12/19/2001
NT 10-QNT 10-Q-Formular12/18/2001
SC 13DSC 13D-Formular12/13/2001
S-8S-8-Formular12/6/2001
S-8S-8-Formular10/30/2001
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/22/2001
S-8S-8-Formular9/21/2001
10KSB/A10KSB/A-Formular9/21/2001
10QSB/A10QSB/A-Formular9/20/2001
10QSB10QSB-Formular9/12/2001
10KSB10KSB-Formular8/10/2001
NTN 10KNTN 10K-Formular8/1/2001
S-8S-8-Formular6/8/2001
10QSB10QSB-Formular3/14/2001
4Insidertransaktion12/29/2000
4Insidertransaktion12/29/2000
4Insidertransaktion12/29/2000
4Insidertransaktion12/29/2000
33-Formular12/29/2000
33-Formular12/29/2000
10QSB10QSB-Formular12/4/2000
10QSB10QSB-Formular9/15/2000
10KSB10KSB-Formular8/10/2000
NT 10-KNT 10-K-Formular7/27/2000
10QSB10QSB-Formular3/24/2000
NT 10-QNT 10-Q-Formular3/15/2000
10SB12G10SB12G-Formular12/20/1999

Humatech Documents 2026

This page contains all official documents and SEC filings for Humatech stock (HUMT, ISIN: US4448861058). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 99 documents are available. Data is updated regularly to provide investors with a complete overview of Humatech's regulatory filings.

Humatech Stock analysis

Humatech Humatech Inc is an international company that specializes in the development, production, and marketing of products for the healthcare industry. The company was founded in 1983 and has since adapted its business models and strategies to meet the changing demands of the market. It is now headquartered in Virginia, USA and operates on multiple continents. The business model of Humatech Inc focuses on the manufacturing of diagnostic and testing products for laboratory and clinical facilities. These products are designed for the diagnosis of diseases such as cancer, diabetes, pregnancy, thyroid problems, and many others. The company also offers HIV, hepatitis, and troponin tests. The high quality of these products has helped the company establish strong brand recognition and customer loyalty. In addition to its products, Humatech Inc also provides services in various areas to offer comprehensive solutions tailored to individual needs. These services include consulting, software solutions, and training, contributing to optimized and efficient operations in medical facilities and laboratories. The different divisions of Humatech Inc encompass a wide range of products and services. The category of diagnostic and testing products forms the core of the company, including tests for diabetes, pregnancy, thyroid problems, cancer, HIV, and hepatitis. The range also includes specialized tests for kidney problems and heart diseases. The company is constantly striving to expand its range of tests for new health issues. Under the category of consulting services, Humatech Inc offers in-depth knowledge of current medical developments, diagnostic procedures, and testing methods. Customers can choose from a wide range of services, including the development of specific test procedures, marketing support, and workflow optimization. The "software solutions" business field includes a variety of online tools to support diagnostic procedures and tests. The software allows medical facilities and laboratories to automate their workflow, manage and analyze data, and quickly retrieve test results. To provide customers with added value, Humatech Inc also offers a range of training programs. These not only cover the operation and application of the products, but also teach optimal work and result processes. Overall, Humatech Inc is an important player in the healthcare industry. By focusing on the development and marketing of diagnostic and testing products, the company is able to sustainably convince its customers through high product quality and services. The wide product range, services, and extensive network of employees, consultants, and customers make the company a forward-thinking service provider.